DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
64.3%
Neutral
35.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $65 |
30%
upside
| 2 | +4.5% |
0
%
| 9 Oct ‘25 11 days ago |
|
|
|
Overweight
Maintained
| $342 |
14%
upside
| 5 | +3% |
0
%
| 25 Aug ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $118 |
17%
downside
| 2 | – |
–
| 14 Aug ‘25 2 months ago |
|
|
|
Overweight
Assumed
| $231 |
1%
upside
| 1 | +16% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $25 |
5%
upside
| 3 | – |
–
| 8 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $121 |
54%
upside
| 3 | +9.9% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $175 |
25%
upside
| 3 | +2.7% |
0
%
| 31 Jul ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $8.50 |
2%
downside
| 2 | +67% |
0
%
| 17 Jun ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $18 |
94%
upside
| 1 | +15% |
0
%
| 15 May ‘25 5 months ago |
|
|
|
Neutral
Reiterated
| $37 |
9%
upside
| 2 | – |
–
| 9 May ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| $147 |
8%
upside
| 4 | +4.7% |
0
%
| 7 May ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $65 |
49%
upside
| 1 | -11% |
0
%
| 22 Apr ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $9 |
6%
downside
| 2 | +1.7% |
0
%
| 21 Mar ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $4 |
57%
downside
| 2 | – |
–
| 7 Mar ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $13 |
47%
downside
| 2 | +79% |
0
%
| 6 Mar ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $10 |
2%
downside
| 2 | – |
–
| 5 Mar ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $30 |
55%
upside
| 1 | -11% |
0
%
| 17 Jan ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $132 |
0%
upside
| 1 | – |
–
| 14 Jan ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $13 |
15%
downside
| 1 | +42% |
0
%
| 10 Jan ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $11 |
11%
upside
| 1 | +14% |
0
%
| 11 Nov ‘24 11 months ago |
|
|
|
Overweight
Reiterated
| $37 |
22%
upside
| 1 | +13% |
0
%
| 25 Oct ‘24 1 year ago |
|